← Leaderboards
Katherine B Sims
Massachusetts General Hospital
$19,079
Attributed
$19,079
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $15.9K · FY2007–08$20K$15K$10K$5K$0
'07
'08
Funding mix
By agency
NIH$19,079 · 4
By mechanism
M01$19,079 · 3
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Schahram Akbarian$48,610,378
- Vijaya Ramesh$9,458,883
- Xandra Owens Breakefield$30,735,276
- Steven E Arnold$15,876,281
- Thomas Force$10,984,600
Others in their field
Top investigators on “Acids”
- Eric S Lander · Whitehead Institute For Biomedical Res$346,225,799
- Richard A Gibbs · Baylor College Of Medicine$207,450,549
- Robert H Waterston · Washington University$167,167,875
- Richard K. Wilson · Washington University$108,492,348
- Michael P Snyder · Yale University$79,863,532
- Kristin Ardlie · Genomics Collaborative, Inc.$59,282,753
Research focus
AcidsComputer Retrieval Of Information On Scientific Projects DatabaseDrug KineticsEnzymesFundingGlucosidaseGlycogenGlycogen Storage Disease Type IiGrantInstitutionRare DiseasesResearch PersonnelResourcesSafetySiteSourceUnited States National Institutes Of HealthTuberous SclerosisMedical Outreach /Case FindingMolecular Biology Information SystemNerve Sheath NeoplasmBiomedical FacilityClinical TrialsNeurofibromatosis
Grant awards (5)
CLINICAL TRIAL: AGLU02704: LATE-ONSET POMPE DISEASE TREATMENT STUDY$11,008
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: AGLU02704: LATE-ONSET POMPE DISEASE TREATMENT STUDY$4,857
M01 · FY2008 · RR · contact PI
AGLU02704: LATE-ONSET POMPE DISEASE TREATMENT STUDY$3,214
M01 · FY2007 · RR · contact PI
CORE--PATIENTS$0
P01 · FY2002 · NS
CORE--PATIENTS$0
P01 · FY2001 · NS